A vitamin-free minimal synthetic medium for Cryptococcus neoformans

Mycopathologia

Volumn 133, Issue 3, 1996, Pages 139-142

  Vidotto, V ^a   Aoki, S ^b   Campanini, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

Cryptococcus neoformans; growth; medium; physiology; thiamine; vitamins

Indexed keywords

FILOBASIDIELLA NEOFORMANS;

EID: 0029831746     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02373020     Document Type: Article

References (38)

1. Aguirremboa L, Montejo M, Prieta R, Uterga J, Gaztelurrutia L, Arce MD, Aguirre C. Meningitis criptococica y SIDA. Description clinica de 10 pacientes. Enfer Infecc Microbiol Clin 1992; 10(2): 97-102.
2. Ainassie E, Paetznik V, Profitt R, Adler-Moore J, Bodey GP. Comparison of the in vitro activity of free and liposome-encapsulated amphotericin B. Eur J Clin Microbiol Infect Dis 1991; 10(8): 665-368.
3. Cameron ML, Bartlett JA, Gallis HA, Waskin HA. Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. Rev Infect Dis 1991; 13(1): 64-67.
4. Capell MS, Hassan T. Pancreatic disease in AIDS - a review. J Clin Gastroenterol 1993; 17(3): 254-263.
5. Gazapo Carretero E, Garcia Aguado C, Andrados de Llano M, Martinez Blanco ML, Verdejo Ortes J, Gonzales Lahos JM. Criptococcosis en pacientes con SIDA: estudio de 19 casos. Rev Clin Esp 1992; 190(9): 450-454.
6. Ghigliotti G, Carrega G, Farris A, Burroni A, Nigro A, Pagano G, De Marchi R. Cutaneous cryptococcosis resembling molluscum contagiousum in a homosexual man with AIDS. Report of case and review of the literature. Acta Derm Venerol (Stockl) 1992; 72(3): 182-184.
7. Huctinson DO, Anderson NE, Ingram RJ, Thomas MG, Ellis-Pegler RB, Bremmer DA, Parr DH. Cryptococcal meningitis in Auckland 1969-1989. NZ Med J 1991; 104(906): 57-59.
8. Joseph J, Strange C, Sahn C. Pleural effusions in hospitalized patients with AIDS. Ann Intern Med 1993; 118(11): 856-859.
9. Kaminaga Y, Shindo K, Ito A, Izima H. Mycological and clinical study of cryptococcosis in Yokohama City University Hospital during the period from 1965 to 1989. Kansenshougaku Zasshi (J Jpn Assoc Inf Dis) 1991; 65(4): 374-380.
10. Knight FR, Mackenzie DW, Evans BG, Porter K, Barret NJ, White GC. Increasing incidence of cryptococcosis in the United Kingdom. J Infect 1993; 27(2): 185-191.
11. Laroche R, Dupont B, Touze JE, Taelman H, Bogaerta J, Kadio A, M'Pele P, Latif A, Aubry P, Durbec JP et al. Cryptococcal meninigits associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatments with fluconazole. J Med Vet Mycol 1992; 30(1): 71-78.
12. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991; 13(6): 1163-1169.
13. Macon WR, Lo SC, Poiesz BJ, Montefiori DC, Dawson MS, Mason TE, Michael PR, Cohen AG, Davis CM, Cousar JB et al. Acquired immunodeficiency syndrome-like illness associated with systemic Mycoplasma fermentans infection in a human immunodeficiency virus-negative homosexual man. Hum pathol 1993; 24(5): 554-558.
14. Martinez Vasquez C, De la Fuente J, Rivera A, Sopeña B, Bordon J, Ocampo A, Alvarez M. Criptococcosis del sistema nervioso central e infection por VIH. Caracteristicas clinico-evolutivas de 13 casos. An Med Interna 1993; 10(6): 265-270.
15. Medoff G, Dismukes WE, Pappagianis D, Diamond R, Gallis HA, Drutz D. Evaluation of new antifungal drugs for the treatment of systemic fungal infections. Infections Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; Nov. 15: 1P S2474-2781.
16. Nichols L, Florentine B, Lewis W, Sattler, Rarick MU, Brynes RK. Bone marrow examination for the diagnosis of mycobacterial and fungal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991; 115(11): 1125-32.
17. Richardson MD. Opportunistic and pathogenic fungi. J Antimicrob Chemother 1991; 28: 1-11.
18. Sider L, Gabriel H, Curry DR, Pham MS. Pattern recognition of the pulmonary manifestations of AIDS on CT scans. Radiographies 1993; 13(4): 771-84.
19. Spitzer ED, Spitzer SG, Freudlich LF, Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 1993; 341(8845): 595-596.
20. Staensell JD. Fungal disease in HIV-infected persons: cryptococcosis, histoplasmosis and coccidioidomycosis. J Thorac Imaging 1991; 6(4): 28-35.
21. Stern JJ, Piertoski NA, Buckley RM, Braffman MN, Rinaldi MG. Parenteral and oral fluconazole for acute cryptococcal meningitis in AIDS: experience with thirteen patients. Ann Pharmacother 1992; 26(7-8): 876-882.
22. Sugar AM. Overview: cryptococcosis in the patient with AIDS. Mycopathologia 1991; 114(3): 153-157.
23. Szalka A, Printz G. Opportunistic systemic mycosis. Orv Hetil 1991; 132(34): 1851-1856.
24. Anaissie E, Shawar R, Paetznik V, Ensign LG, Zitta W, LaRocco M. Two-site comparison of broth microdilution and semi-solid agar dilution methods for suceptibility testing of Cryptococcus neoformans in three media. J Clin Microbiol 1993; 31(5): 1370-1372.
25. Ghannoum MA, Ibrahim AS, Yue F, Shafiq MC, Edwards JE Jr, Criddle RS. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol 1992; 30(11): 2881-2886.
26. Kao CJ, Schwarz J. The isolation of Cryptococcus neoformans from pigeon nests. Am J Clin Pathol 1957; 27: 652-663.
27. Littman ML. Capsule synthesis by Cryptococcus neoformans. Trans NY Acad Sci 1958; 30: 623-648.
28. Varma A, Kwon-Chung KJ. DNA probe for strain typing of Cryptococcus neoformans. J. Clin Microbiol 1992; 30(11): 2960-2967.
29. Vartivarian SE. Iron assimilation in Cryptococcus neoformans. J Med Vet Mycol 1992; 30(6): 443-450.
30. Wickerham LJ, Burton KA. Carbon assimilation tests for the classification of yeasts. J Bacteriol 1948; 56: 363-371.
31. Yamamoto T, Nohara K, Uchida K, Yamaguchi H. Purification and characterization of secretory proteinase of Candida albicans. Microbiol Immunol 1992; 36(6): 637-641.
32. Sevilla MG, Odds FC. Development of Candida albicans hyphae in different growth media-variations in the growth rates, cell dimensions and timing of morphogenetic events. J Gen Microbiol 1986; 32: 3083-3088.
33. Shepherd MG, Chiew YY, Ram SP, Sullivan PA. Germ tube induction in Candida albicans. Can J Microbiol 1980; 26: 21-26.
34. Vidotto V, Guevara Ochoa L, Michea Cortes J, Bruatto M. Optimal concentration of ammonium ion in a minimal synthetic medium for the growth of Candida albicans. Mycopathologia 1991; 100: 139-142.
35. Vidotto V, Pugliese A, Gioannini P. 1987. Growth of Candida albicans in a minimal synthetic medium without biotin. Mycopathologia 1987; 106: 7-15.
36. Bruatto M, Vidotto V, Maina AM. Growth of Cryptococcus neoformans in a thiamine-free medium. Mycopathologia 1992; 119(3): 129-132.
37. Shields AB, Ajello L. Medium for selective isolation of Cryptococcus neoformans. Science 1966; 151: 208-210.
38. Staib F, Seeliger HPR. Un noveau milieu selectif pour l'isolement de cryptococcus neoformans. Ann Inst Pasteur 1966; 110: 792-793.